Diagnostic value of HHV-6A/B genotyping in immunocompromised adults
Journal of Clinical Microbiology · 12.08.2026 · 64 (8)
DOI: 10.1128/jcm.01898-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.08.2026. Verfasst von Virginia Rodríguez-Lorente und 15 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomè…. Hauptthemen laut MEDLINE: Herpesvirus 6, Human, Immunocompromised Host, Genotype, Roseolovirus Infections. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHV-6 Foundation.
Abstract (Originalsprache)
Human herpesvirus 6 (HHV-6) comprises two genetically and biologically distinct species, HHV-6A and HHV-6B, yet species-level differentiation is rarely performed in clinical practice. We conducted a retrospective study of 119 immunocompromised adults with detectable HHV-6 DNA between 2020 and 2025 to characterize species distribution, compare epidemiological, clinical, and virological features, and evaluate the diagnostic relevance of genotyping. Viral species were detected by real-time polymerase chain reaction (PCR) across multiple sample types, and suspected chromosomal integration was confirmed through detection of endogenous HHV-6 (eHHV-6) DNA in hair follicles by quantitative real-time PCR. HHV-6B accounted for ~96% of infections and was significantly associated with organ involvement, predominantly gastrointestinal disease, irrespective of plasma viral load. In contrast, HHV-6A was less frequently detected in tissues and was consistently associated with viremia and chromosomal integration, independent of viral load. Genotypic concordance across plasma, biopsy, cerebrospinal fluid, bronchoalveolar lavage, and hair follicle samples from the same patient was complete. Incorporating species-level genotyping and targeted testing for chromosomal integration (eHHV-6) into diagnostic workflows may improve interpretation of viral detection and help prevent unnecessary antiviral therapy. IMPORTANCE Species-specific identification of human herpesvirus 6 (HHV-6A/B) has critical diagnostic implications in immunocompromised patients, although it is rarely performed in diagnostic laboratories. Our study showed that HHV-6A detection is associated with chromosomal integration, whereas HHV-6B is the main species linked to clinically relevant disease and invasive tissue infection. This study emphasizes that implementing species-specific PCR and testing for eHHV-6 in clinical microbiology laboratories may help interpret viral DNA detection, prevent misclassification of integrated virus as active infection, and avoid unnecessary antiviral therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
- Hematology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
- Infectious Diseases Department, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), CIBER-ISCIII, Instituto de Salud Carlos III, Madrid, Spain.
- Microbiology Department, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
- Infectious Diseases Department, Hospital Universitario Reina Sofía, Universidad de Barcelona, IMIBIC, Córdoba, Spain.
ORCID-Profile: Virginia Rodríguez-Lorente, Paola Charry, Francesc Fernández-Avilés, María Queralt Salas, Carmen Martínez, Laura Rosiñol, Marta Bodro, Ana Belén Pérez, Isabel Machuca, María Del Mar Mosquera, Miguel J Martínez, María Suárez-Lledó, María Ángeles Marcos
Förderung
- HHV-6 Foundation
Zitieren
APA
Rodríguez-Lorente, V., Charry, P., Guardia, A., Fernández-Avilés, F., Rovira, M., Salas, M. Q., Martínez, C., Rosiñol, L., Bodro, M., Pérez, A. B., Machuca, I., Cervilla, A., Mosquera, M. M., Martínez, M. J., Suárez-Lledó, M., & Marcos, M. Á. (2026). Diagnostic value of HHV-6A/B genotyping in immunocompromised adults. Journal of Clinical Microbiology, 64(8). https://doi.org/10.1128/jcm.01898-25
Vancouver
Rodríguez-Lorente V, Charry P, Guardia A, Fernández-Avilés F, Rovira M, Salas MQ, et al. Diagnostic value of HHV-6A/B genotyping in immunocompromised adults. Journal of Clinical Microbiology. 2026;64(8). doi:10.1128/jcm.01898-25
BibTeX
@article{RodrguezLorente2026,
author = {Rodríguez-Lorente, Virginia and Charry, Paola and Guardia, Ares and Fernández-Avilés, Francesc and Rovira, Montserrat and Salas, María Queralt and Martínez, Carmen and Rosiñol, Laura and Bodro, Marta and Pérez, Ana Belén and Machuca, Isabel and Cervilla, Ana and Mosquera, María Del Mar and Martínez, Miguel J and Suárez-Lledó, María and Marcos, María Ángeles},
title = {Diagnostic value of HHV-6A/B genotyping in immunocompromised adults},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {8},
doi = {10.1128/jcm.01898-25}
}
EUVIMED